Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2025 Q3
2 of 19 quarters
Total Value
$27.61M
Total Shares
8.47M
Net Share Change
+104.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$27.61M
8.47M
0.4%
ADD
+104.5K
(+1.2%)
Maverick Capital
$27.61M
8.47M shares
ADD
+104.5K
(+1.2%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy